Effects of the Tyrosine Kinase Inhibitor Imatinib on Neuroendocrine Tumor Cell Growth

By  

Digestion, Vol. 71, Iss. 3, 2005-06 ,pp. : 131-140

Karger

Access to resources Recommend Favorite

Role of Tyrosine Kinase Inhibitor Molecules in Non Small Cell Lung Cancer:From Benchside to Bedside

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 159-167

Bentham Science Publishers

Access to resources Recommend Favorite

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

By Drevs J.  

Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. : 347-354

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Vascular Endothelial Growth Factor-Associated Tyrosine Kinase Activity with SU5416 Blocks Sprouting in the Microvascular Endothelial Cell Spheroid Model of Angiogenesis

By Haspel H.C.   Scicli G.M.   McMahon G.   Scicli A.G.  

Microvascular Research, Vol. 63, Iss. 3, 2002-05 ,pp. : 304-315

Academic Press

Access to resources Recommend Favorite

Everolimus zur Behandlung des metastasierten Nierenzellkarzinoms nach Versagen der ersten VEGFr-TKI(Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor)-Therapie: Ergebnisse einer Interimsanalyse einer nichtinterventionellen Studie

By  

Karger Kompass Onkologie, Vol. 1, Iss. 1, 2014-01 ,pp. : 28-29

Karger

Access to resources Recommend Favorite